glp-1 reimbursement news Pfizer, Innovent drugs clear China insurance hurdle GLP-1 Shortage = Over -

Appetite suppression may lead to smaller basket sizes, fewer impulse purchases, increased demand for high-protein, high fiber and nutrient-dense, portion-controlled options and greater scrutiny of ingredient formulations in food and drinks

No membership fees, no insurance requirement, and HSA/FSA eligibility mean patients control their own healthcare spending

Ozempic and Zepbound branded options are listed at $1,299/month and $1,399/month respectively - substantially higher, which reflects the cost of FDA-approved branded medications versus compounded alternatives

And unlike crash diets or stimulant-based approaches, this weight loss occurred through sustainable metabolic mechanisms, reduced appetite, improved fat oxidation, and increased energy expenditure, rather than through deprivation or artificial stimulation